Neutron beam radiotherapy for recurrent prostate cancer following radical prostatectomy

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 1, 1998, Pages 93-99

  Raymond, James F ^a   Vuong, Monica ^a   Russell, Kenneth J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Neutrons; Prostate cancer; Prostate specific antigen; Radical prostatectomy; Radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; HUMAN; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE; TREATMENT OUTCOME;

AGED; COMBINED MODALITY THERAPY; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUTRONS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 0032053678     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00033-9     Document Type: Article

References (26)

1. Hudson M. A., Catalona W. Effect of adjuvant radiation therapy on prostate specific antigen following radical prostatectomy. J. Urol. 143:1990;1174-1177.
2. Kaplan I. D., Bagshaw M. A. Serum prostate-specific antigen after post-prostectomy radiotherapy. Urology. 39:1992;401-406.
3. Lange P. H., et al. The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. J. Urol. 144:1990;927-933.
4. Link P., Freiha F. S., Stamey T. A. Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy. J. Urol. 145:1991;532-534.
5. Schild S. E., et al. Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy. Mayo Clin. Proc. 69:1994;613-619.
6. Schild S. E., et al. The results of radiotherapy for isolated elevation of serum PSA levels following radical prostatectomy. Int. J. Radiat. Oncol. Biol. Phys. 23:1992;141-145.
7. Stamey T. A., et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med. 317:1987;909-916.
8. Haraf D. J., et al. Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 33:1995;3-14.
9. Hall E. J. Radiobiology for the radiologist, 4th ed. 1994;153-243 J. B. Lippincott Company, Philadelphia, PA.
10. Laramore G. E., et al. Fast neutron radiotherapy for locally advanced prostate cancer. Am. J. Clin. Oncol. 16:1993;164-167.
11. Russell K. J., et al. Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer Results of a randomized prospective trial . Int. J. Radiat. Oncol. Biol. Phys. 28:1993;47-54.
12. Kaplan E. L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:1958;457-481.
13. Takayama T. K., Lange P. H. Radiation therapy for local recurrence of prostate cancer after radical prostatectomy. Urol. Clin. North Am. 21:1994;687-700.
14. Zeitman A. L., et al. Adjuvant irradiation after radical prostatectomy for adenocarcinoma of prostate Analysis of freedom from PSA failure . Urology. 42:1993;292-299.
15. Ray G. R., Bagshaw M. A., Freiha F. External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy. J. Urol. 132:1984;926-930.
16. Keisch M. E., et al. Preliminary report on 10 patients treated with radiotherapy after radical prostatectomy for isolated elevation of serum PSA levels. Int. J. Radiat. Oncol. Biol. Phys. 19:1990;1503-1506.
17. Partin A. W., et al. Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology. 43:1994;649-659.
18. Partin A. W., et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J. Urol. 150:1992;110-114.
19. Buskirk S. J., et al. Evaluation of serum prostate-specific antigen levels after postoperative radiation therapy for pathologic stage T3, N0 prostate cancer. Mayo Clin. Proc. 71:1996;242-248.
20. Coetzee L. J., Hars V., Paulson D. F. Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy. Urology. 47:1996;232-235.
21. McCarthy J. F., Catalona W. J., Hudson M. A. Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy Early versus delayed treatment . J. Urol. 151:1994;1575-1578.
22. Leibel S. A., et al. The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement. Int. J. Radiat. Oncol. Biol. Phys. 28:1993;7-16.
23. Asbell S. O., et al. Elective pelvic irradiation in stage A2, B carcinoma of the prostate Analysis of RTOG 77-06 . Int. J. Radiat. Oncol. Biol. Phys. 15:1988;1307-1316.
24. Zagars G. K., et al. Stage C adenocarcinoma of the prostate An analysis of 551 patients treated with external beam radiation . Cancer. 60:1987;1489-1499.
25. Bagshaw M. A. Radiotherapeutic treatment of prostatic carcinoma with pelvic node involvement. Urol. Clin. North Am. 11:1984;297-304.
26. Austin-Seymour M., et al. Impact of multileaf collimator on treatment morbidity in localized carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 30:1994;1065-1071.